← Back to the fund pageUse your browser's print dialog and choose “Save as PDF”. A4, two pages.
InvestVerdict
UTI Ultra Short Term Fund
Direct Plan · Monthly IDCW · Ultra Short Duration · Scheme code 131444
NAV₹1,175.9532as on 28 Aug 2026
Fund houseUTI Mutual Fund
CategoryUltra Short Duration
Plan & optionDirect · Monthly IDCW
History11.4 years
Returns (%)
1M
3M
6M
1Y
3Y
5Y
7Y
10Y
Launch
This scheme
0.13
0.73
0.81
1.24
1.85
1.60
1.15
0.81
1.04
Ultra Short Duration category median
—
—
—
6.41
7.22
6.51
—
6.66
—
Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published
NAV history for this scheme.
Risk
Volatility
Sharpe
Sortino
Beta
Alpha
Max fall
R²
This scheme
2.0%
-2.29
-2.51
—
—
-4.1%
—
Risk-free rate 6.5%. Beta, alpha and R² are regressed on the
— months this scheme and its benchmark share.
Growth of ₹100 since launch
Drawdown from peak (%)
Every one-year period it has lived through
Windows
Worst
Median
Best
Periods that lost money
505
-3.1%
1.2%
2.8%
20%
Every one-year holding period in this scheme's history, not just the last one — the
spread a real investor would have met depending only on when they started.
InvestVerdict
UTI Ultra Short Term Fund
Direct Plan · Monthly IDCW
Allocation
By asset
Debt
94.32%
Cash & Equivalents
4.95%
REITs / InvITs
0.72%
By market cap
Concentration
Number of stocks
55
Top 5 stocks
21.25%
Top 10 stocks
35.30%
Top 20 stocks
56.26%
Largest holding
5.71%
Largest sector
CRISIL-A1+ 36.56%
Effective stocks
43.8
Cash
4.95%
InvestVerdict
UTI Ultra Short Term Fund
Direct Plan · Monthly IDCW · holdings
Sector split
CRISIL-A1+
36.56%
CARE-A1+
9.13%
SOV
8.62%
ICRA-A1+
7.73%
CRISIL-AA+
6.52%
ICRA-AA+
5.10%
Cash & Equivalents
4.95%
ICRA-AA
4.37%
IND-A1+
3.57%
CARE-AA
2.92%
A ₹10,000 monthly SIP over five years
Invested
Value
Gain
XIRR
₹600,000
₹625,240
₹25,240
1.63%
XIRR, not CAGR — a SIP's money arrives over sixty months, so each instalment has
been invested for a different length of time.
Not investment advice. InvestVerdict is not a SEBI-registered Investment
Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the
portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past
returns do not predict future ones. Generated 30 Aug 2026.